SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

20 Jan 2024 Evaluate
The sales for the December 2023 quarter moved down to Rs. 860.69 millions as compared to Rs. 1135.37 millions during the year-ago period.Net Profit of the company move down -55.94% to Rs. 46.51  millions from Rs. 105.57 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 135.22 millions from 179.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 860.69 1135.37 -24.19 2847.47 2836.40 0.39 4030.44 4278.11 -5.79
Other Income 12.09 10.73 12.67 29.80 48.94 -39.11 56.78 106.29 -46.58
PBIDT 135.22 179.20 -24.54 556.47 441.72 25.98 603.56 1163.97 -48.15
Interest 3.77 23.84 -84.19 62.89 52.05 20.83 83.84 49.51 69.34
PBDT 131.45 155.36 -15.39 493.58 389.67 26.67 483.85 1114.46 -56.58
Depreciation 65.82 23.83 176.21 193.69 70.24 175.75 95.54 81.80 16.80
PBT 65.63 131.53 -50.10 299.89 319.43 -6.12 388.31 1032.66 -62.40
TAX 19.12 25.96 -26.35 88.87 76.30 16.47 -16.34 72.79 -122.45
Deferred Tax 5.91 4.59 28.76 36.70 12.12 202.81 -35.93 -107.29 -66.51
PAT 46.51 105.57 -55.94 211.02 243.13 -13.21 404.65 959.87 -57.84
Equity 233.92 221.65 5.54 233.92 221.65 5.54 221.65 221.65 0.00
PBIDTM(%) 15.71 15.78 -0.46 19.54 15.57 25.49 14.98 27.21 -44.96

Tatva Chintan Pharma Share Price

1275.10 -8.55 (-0.67%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×